Data / Drug companies / Belmora LLC
Belmora LLC: 24 products in the FDA NDC directory, labeler code 27854
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Belmora LLC (labeler code 27854) lists 24 products in the FDA National Drug Code Directory, covering 14 finished drugs by generic name. By type: 24 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on May 27, 2025.
The request: Watch Belmora LLC (FDA labeler code 27854): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 27854
- Products in commercial distribution
- 24
- Packages
- 29
- Finished drugs by generic name
- 14
- Prescription products
- 0
- Over the counter products
- 24
- Flagged as original packager
- 21 of 21 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 23, 2017
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 14 | 58.3% |
| Generic drugs (ANDA) | 10 | 41.7% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 24 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Naproxen sodium | 7 | 100 |
| Lidocaine | 2 | 216 |
| Aluminum hydroxide, magnesium hydroxide, simethicone | 2 | 20 |
| Acetaminophen | 1 | 214 |
| Eugenol | 1 | 2 |
| Ivermectin | 1 | 33 |
| Ibuprofen | 1 | 190 |
| Camphor, eucalyptus oil, menthol | 1 | 32 |
| Calcium carbonate | 1 | 101 |
| Methyl salicylate, menthol, capsaicin | 1 | 6 |
| Acetaminophen, aspirin, caffeine | 1 | 48 |
| Benzocaine | 1 | 110 |
| Doxylamine succinate | 1 | 39 |
| Aspirin, caffeine | 1 | 11 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 6 | 25% |
| Tablet | 3 | 12.5% |
| Gel | 2 | 8.3% |
| Patch | 2 | 8.3% |
| Suspension | 2 | 8.3% |
| Capsule, liquid filled | 1 | 4.2% |
| Solution | 1 | 4.2% |
| Lotion | 1 | 4.2% |
| Jelly | 1 | 4.2% |
| Liquid | 1 | 4.2% |
| Tablet, chewable | 1 | 4.2% |
| Liniment | 1 | 4.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Chest Rub | 27854-399 | Jelly | Over the counter monograph drugs | May 27, 2025 |
| Ivermectin | 27854-334 | Lotion | Generic drugs (ANDA) | August 12, 2024 |
| Flanax | 27854-499 | Liniment | Over the counter monograph drugs | August 1, 2024 |
| Cafiaspirina Rapid Headache Relief | 27854-755 | Powder | Over the counter monograph drugs | June 30, 2024 |
| Sedalmex forte | 27854-303 | Tablet | Over the counter monograph drugs | June 1, 2024 |
| Childrens FLANAX ORAL | 27854-777 | Suspension | Generic drugs (ANDA) | January 26, 2024 |
| Melox | 27854-117 | Liquid | Over the counter monograph drugs | May 1, 2023 |
| AnaDent Childrens Kanka Gel | 27854-178 | Gel | Over the counter monograph drugs | November 8, 2022 |
| Anadent Kanka Gel | 27854-177 | Gel | Over the counter monograph drugs | April 15, 2022 |
| Sedalmex XL Flu | 27854-350 | Tablet, film coated | Over the counter monograph drugs | March 24, 2022 |
| Complete Cold Relief | 27854-299 | Solution | Over the counter monograph drugs | February 23, 2022 |
| Regular Strength Pain Relief | 27854-388 | Capsule, liquid filled | Over the counter monograph drugs | January 5, 2022 |
| Flanax Back Pain Relief | 27854-333 | Patch | Over the counter monograph drugs | December 15, 2021 |
| Belmora Flanax | 27854-555 | Tablet | Generic drugs (ANDA) | July 20, 2020 |
| Ana-Dent PAIN RELIEF | 27854-701 | Tablet, film coated | Generic drugs (ANDA) | May 15, 2020 |
| Flanax Pain Reliever/Fever Reducer | 27854-700 | Tablet, film coated | Generic drugs (ANDA) | May 15, 2020 |
| Flanax Pain Reliever/Fever reducer | 27854-505 | Tablet, coated | Generic drugs (ANDA) | May 15, 2020 |
| Flanax back pain relief | 27854-311 | Patch | Over the counter monograph drugs | February 1, 2020 |
| Nocto Sleep Aid | 27854-375 | Tablet | Generic drugs (ANDA) | October 31, 2019 |
| Belmora MELOX AGRURA | 27854-120 | Tablet, chewable | Over the counter monograph drugs | June 3, 2019 |
| Melox | 27854-115 | Suspension | Over the counter monograph drugs | June 1, 2018 |
| Flanax | 27854-160 | Tablet, film coated | Generic drugs (ANDA) | January 15, 2018 |
| AnaDent | 27854-170 | Tablet, film coated | Generic drugs (ANDA) | January 23, 2017 |
| Flanax Menstrual Pain Reliever | 27854-165 | Tablet, film coated | Generic drugs (ANDA) | January 23, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.